Skip to main content

Peer Review reports

From: TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab

Original Submission
9 Apr 2012 Submitted Original manuscript
25 Jun 2012 Reviewed Reviewer Report - Oliver Neuhaus
10 Jul 2012 Reviewed Reviewer Report - Thomas Scott
27 Aug 2012 Author responded Author comments - Celia Oreja-Guevara
Resubmission - Version 2
27 Aug 2012 Submitted Manuscript version 2
28 Aug 2012 Reviewed Reviewer Report - Thomas Scott
11 Sep 2012 Reviewed Reviewer Report - Oliver Neuhaus
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
11 Sep 2012 Editorially accepted
18 Sep 2012 Article published 10.1186/1471-2377-12-95

You can find further information about peer review here.

Back to article page